VetSheet

Chromium Picolinate

Chromium tripicolinate

Also known as: Chroma-Pak Β· Chromium tripicolinate Β· Cr III

Reviewed by the VetSheet Veterinary TeamUpdated Apr 5, 2026Evidence-based veterinary reference

Chromium picolinate 20 micrograms/kg PO every other a dayPOΒ· q48h
β€” 🐈

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Dosing by species

🌎 NA β€” North America🌍 EU β€” Europe

Cats

IndicationDoseRouteFrequencyDurationRegion
For use as an oral hypoglycemic agentChromium picolinate 200 micrograms (per cat) PO once a day.POq24hβ€”πŸŒŽ NA
For adjunctive treatment of feline obesityChromium picolinate 20 micrograms/kg PO every other a dayPOq48hβ€”πŸŒŽ NA

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Recording this consult? VetSheet's AI writes the drug, dose and duration straight into a structured visit note.See how VetSheet works

Overview

Chromium picolinate is a trace metal nutraceutical that may be used as an adjunctive treatment for diabetes mellitus and obesity, particularly in cats.

  • Clinical Efficacy: Its efficacy remains controversial in veterinary medicine, and it does not appear to be useful in dogs with diabetes mellitus.
  • Biologic Forms: Trivalent chromium (Cr III) is the biologically active form found in supplements and food, which is distinct from the highly toxic and carcinogenic hexavalent chromium (Cr VI) used in industrial applications.
  • Safety: Generally considered safe at recommended dosages, though its true clinical benefit requires individual patient trials.

Mechanism of action

Chromium is an active component of the ​glucose tolerance factor (GTF)​, a complex of molecules including glycine, glutamic acid, cysteine, and nicotinic acid.

While its exact role in carbohydrate and nitrogen metabolism is not fully elucidated, it is thought to enhance insulin receptor sensitivity and facilitate glucose transport into cells.

  • GTF β†’ Insulin Receptor Binding β†’ Enhanced Intracellular Glucose Uptake
  • It does not lower blood glucose levels in normal, healthy patients.

Safety & warnings

Contraindications

  • Renal insufficiency (use with caution)

Adverse effects

  • Cognitive, perceptual, and motor dysfunction (reported in humans receiving the picolinate salt)

Precautions

Renal Insufficiency: Chromium supplements could potentially exacerbate renal insufficiency; use with caution in these patients. Behavioral Alterations: Because the picolinate salt can potentially alter behavior, consider using chromium chloride or chromium nicotinate in patients receiving SSRIs or other behavioral therapies. Pregnancy: Use cautiously in pregnant animals, especially cats, as they may receive much higher dosages than human equivalents.

Drug interactions

Corticosteroids

May increase the urinary excretion of chromium

H2 Blockers (cimetidine, ranitidine, famotidine) or Proton Pump Inhibitors (omeprazole)

May decrease chromium levels by inhibiting their absorption; clinical significance is unclear

NSAIDs

May increase the absorption and retention of chromium; clinical significance is unlikely

Zinc

Theoretically, co-administration of zinc with chromium could decrease the oral absorption of both

Monitoring

  • Fasting blood glucose
  • Appetite and attitude
  • Body condition and weight
  • PU/PD resolution
  • Serum fructosamine levels
  • Glycosylated hemoglobin levels

Pharmacokinetics

Absorption

Poorly absorbed from the GI tract. When given as a salt (picolinate, chloride, nicotinate), lipophilicity and solubility are increased, enhancing absorption.

Elimination

Most of an oral dose is excreted in the feces. Absorbed chromium is eliminated via the kidneys.

Overdose

Little information on acute overdoses is available. In humans, there are case reports of women developing renal failure after taking excessive doses of chromium picolinate.

Available products

Formulations

  • tablets
  • injection

Human-labeled

  • Injectable chromium (as chromic chloride hexahydrate): 4 micrograms/mL and 20 micrograms/mL
  • Oral tablets (Chromium picolinate): 200 micrograms, 400 micrograms, 500 micrograms, and 800 micrograms

Regulatory status

No regulatory data for: πŸ‡ΊπŸ‡Έ US Β· πŸ‡ͺπŸ‡Ί EU Β· πŸ‡¬πŸ‡§ UK Β· πŸ‡­πŸ‡° HK Β· πŸ‡ΉπŸ‡Ό TW Β· πŸ‡―πŸ‡΅ JP Β· πŸ‡°πŸ‡· KR Β· πŸ‡¦πŸ‡Ί AU

Storage & stability

Store in tight containers. Refer to the specific product label for exact storage recommendations.

Client information

Give this supplement exactly as prescribed by your veterinarian.

  • Consistency is Key: Do not change brands or formulations without your veterinarian's approval, as different products may be absorbed differently.
  • Monitoring: Watch your pet's water intake, urination, and appetite closely to help determine if the treatment is working.

VetSheet drug reference is intended for licensed veterinary professionals as a clinical decision-support aid, not a substitute for professional judgement or the manufacturer’s current label.